Article By:
The Life Sciences Report
Thursday, August 14, 2014 6:48 AM EDT
For former drug researcher Raghuram "Ram" Selvaraju, picking biotech stocks is both science and art. It's about understanding the competitive landscape and the mechanisms of drug action, and then making sure all the pieces fit together for a plausible investment case.